{"gene":"KCNIP3","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2001,"finding":"KChIP3/DREAM is a Ca2+-regulated transcriptional repressor that binds directly to downstream regulatory element (DRE) sites in DNA promoters; binding and repression occur in the Ca2+-free state, and elevated Ca2+ causes derepression by releasing DREAM from DNA.","method":"In vitro DNA-binding assays, Ca2+-dependent transcriptional repression assays, EF-hand mutant analysis","journal":"Seminars in cell & developmental biology","confidence":"High","confidence_rationale":"Tier 1 — foundational mechanism described with direct DNA-binding and mutagenesis, referenced as the original discovery","pmids":["11162748"],"is_preprint":false},{"year":2001,"finding":"KChIP3 (KChip3.1 long splice variant) associates with Kv4.3 α-subunits to form A-type potassium channels in dopaminergic substantia nigra neurons; the number of KChIP3 mRNA molecules in individual neurons correlates linearly with A-type channel density and pacemaker frequency, establishing transcriptional control of KChIP3 as a mechanism for tuning firing rate.","method":"Single-cell RT-PCR quantification combined with patch-clamp electrophysiology in identified dopaminergic neurons","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — quantitative single-cell mRNA-to-current correlation with functional readout, replicated across many neurons","pmids":["11598014"],"is_preprint":false},{"year":2001,"finding":"Calsenilin/DREAM/KChIP3 has a pro-apoptotic function: its overexpression induces apoptosis (cell shrinkage, DNA laddering, caspase activation), and antisense-mediated knockdown attenuates apoptosis induced by Fas, Ca2+-ionophore, or thapsigargin. Apoptosis was suppressed by caspase inhibitor Z-VAD and Bcl-XL. KChIP3 expression also increased Aβ42 production in cells co-expressing APPsw and presenilin 2.","method":"Antisense oligonucleotide knockdown, overexpression, caspase activity assays, DNA laddering, morphological analysis","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function and gain-of-function with defined apoptotic phenotype, single lab","pmids":["11259376"],"is_preprint":false},{"year":2004,"finding":"Induction of calsenilin/DREAM/KChIP3 is observed in Alzheimer's disease cortex and in APP transgenic mouse brain; exposure of cultured neurons to Aβ42 induces KChIP3 protein and mRNA, and blocking KChIP3 expression protects neurons from Aβ toxicity, establishing a role for KChIP3 in Aβ-driven neurodegeneration.","method":"Immunohistochemistry on AD brain tissue, cortical neuron culture with Aβ42 treatment, antisense knockdown, cell viability assays","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2/3 — loss-of-function with specific neuroprotective phenotype, moderate mechanistic follow-up","pmids":["14720210"],"is_preprint":false},{"year":2005,"finding":"KChIP3 and DPP10 associate simultaneously with Kv4.2 to form a ternary Kv4.2/KChIP3/DPP10 macromolecular complex; this ternary complex produces ISA-like currents with very rapid recovery from inactivation (~18–26 ms) distinct from binary Kv4.2+KChIP3 or Kv4.2+DPP10 channels.","method":"Co-immunoprecipitation from rat brain and Xenopus oocytes, heterologous co-expression electrophysiology in oocytes and CHO cells","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal Co-IP in native tissue plus functional reconstitution in two expression systems","pmids":["16123112"],"is_preprint":false},{"year":2004,"finding":"KChIP3 promotes Kv4.2 subunit assembly into tetramers by binding monomeric subunits within the endoplasmic reticulum; KChIP3 rescues functional channel expression of Kv4.2 tetramerization-deficient mutants (Zn2+ site mutants) that are otherwise trapped in the ER, demonstrating a direct role in subunit assembly beyond trafficking.","method":"Mutagenesis of Zn2+-coordination residues in Kv4.2, co-expression with KChIP3, electrophysiology, surface expression assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis plus functional reconstitution clearly defining ER-based assembly role","pmids":["15485870"],"is_preprint":false},{"year":2009,"finding":"KChIP3/DREAM regulates contextual fear memory consolidation: KChIP3 knockout mice show enhanced contextual fear memory. After fear conditioning, membrane association of KChIP3 and its interaction with Kv4.2 decrease, nuclear KChIP3 increases, and prodynorphin mRNA expression decreases in WT but not KO animals, indicating a shift from channel modulation to transcriptional repression.","method":"KChIP3 knockout mouse behavior (contextual fear conditioning), subcellular fractionation, co-immunoprecipitation, RT-PCR","journal":"Learning & memory","confidence":"Medium","confidence_rationale":"Tier 2 — KO behavioral phenotype with mechanistic fractionation and interaction data in single lab","pmids":["19223600"],"is_preprint":false},{"year":2009,"finding":"DREAM/KChIP3 modulates TSH receptor (TSHR) activity through direct protein-protein interaction that promotes coupling between TSHR and Gαs; DREAM overexpression in transgenic mice causes marked thyroid enlargement, and elevated DREAM protein is found in human multinodular goiters.","method":"Protein-protein interaction assay, transgenic mouse model with thyroid phenotype, immunohistochemistry on human goiter tissue","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2/3 — direct interaction demonstrated with in vivo validation in transgenic model, single lab","pmids":["19299442"],"is_preprint":false},{"year":2009,"finding":"PACAP-cAMP signaling promotes astrogliogenesis via a pathway in which cAMP-dependent extracellular Ca2+ entry activates DREAM/KChIP3, which is bound to DRE sites in the GFAP gene promoter, stimulating GFAP expression during astrocyte differentiation. DREAM knockout in vivo alters the numbers of neurons and astrocytes generated during development.","method":"Reporter assays, DREAM knockout mice with developmental phenotype, pharmacological manipulations of cAMP and Ca2+","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 — defined signaling cascade with in vivo KO validation, single lab","pmids":["19238593"],"is_preprint":false},{"year":2010,"finding":"KChIP3 coimmunoprecipitates with Kv4.2 in adult mouse cortex; KChIP2, KChIP3, and KChIP4 together are required interdependently for generation of IA currents in cortical pyramidal neurons — loss of KChIP3 alone reduces IA density modestly but triggers compensatory upregulation of KChIP2 and KChIP4.","method":"Co-immunoprecipitation, KChIP2/3 knockout mice electrophysiology, RNAi triple knockdown of KChIP2/3/4","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP combined with multiple genetic loss-of-function models","pmids":["20943905"],"is_preprint":false},{"year":2010,"finding":"DREAM/KChIP3 acts as a transcriptional repressor controlling B cell proliferation and Ig synthesis; transgenic mice expressing dominant-active DREAM show reduced serum Ig levels due to reduced mRNA translation (linked to decreased Eif4g3) and accelerated B cell division correlated with reduced Klf9 expression.","method":"Transgenic dominant-active DREAM mice, in vitro B cell assays, transcriptomics, pulse-chase protein synthesis experiments","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — transgenic gain-of-function with transcriptomic and translation mechanistic data, single lab","pmids":["21059893"],"is_preprint":false},{"year":2013,"finding":"In the presence of Ca2+, DREAM/KChIP3 interacts directly with hexokinase I; this interaction requires the N-terminal 94 amino acids of DREAM and Ca2+ binding. DREAM overexpression reduces hexokinase I localization on mitochondria and enhances cisplatin-mediated caspase-3 activity; co-expression of hexokinase I reduces DREAM-induced apoptosis.","method":"Co-immunoprecipitation, deletion mutants, Ca2+-binding mutants, caspase-3 activity assays, mitochondrial fractionation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2/3 — direct protein interaction with domain mapping and functional validation, single lab","pmids":["23524266"],"is_preprint":false},{"year":2014,"finding":"NS5806, a Kv4 current activator, binds at a hydrophobic site on the C-terminus of KChIP3 in a calcium-dependent manner (Kd ~2–5 μM calcium-bound form). KChIP3 association with the Kv4.3 N-terminus is itself calcium-dependent. NS5806 increases KChIP3–Kv4.3 affinity and decreases their dissociation rate; Tyr-174 and Phe-218 on KChIP3 are required for drug-enhanced Kv4.3 binding.","method":"Fluorescence spectroscopy, isothermal calorimetry, docking simulations, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding quantification with mutagenesis and multiple orthogonal biophysical methods","pmids":["25228688"],"is_preprint":false},{"year":2018,"finding":"The N-terminal 31–50 fragment of KChIP3 binds directly to both intracellular N- and C-termini of TRPV1, reducing TRPV1 surface localization and Ca2+ influx through the channel. Intrathecal or intraplantar delivery of a TAT-31–50 transmembrane peptide reduces TRPV1-mediated Ca2+ influx in DRG neurons and alleviates inflammatory thermal hyperalgesia in rats.","method":"Co-immunoprecipitation, co-localization, peptide competition, Ca2+ imaging, kcnip3-/- rat model (KO validation), complete Freund's adjuvant inflammatory pain model","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding domain mapping, KO rat validation, and in vivo functional rescue with defined peptide","pmids":["29335353"],"is_preprint":false},{"year":2016,"finding":"Chronic ethanol exposure reduces hippocampal Kv4.2 and KChIP3 protein levels while increasing FMRP phosphorylation at S499 (via S6K1), which increases FMRP translational suppression of Kv4.2 and KChIP3 mRNAs; S6K1 inhibition prevents both the increase in phospho-FMRP and the reduction of Kv4.2/KChIP3 protein.","method":"Western blotting, FMRP-mRNA pulldown from hippocampal slice cultures, pharmacological S6K1 inhibition","journal":"Alcoholism, clinical and experimental research","confidence":"Medium","confidence_rationale":"Tier 2/3 — FMRP-mRNA association assay with pharmacological manipulation, single lab","pmids":["27147118"],"is_preprint":false},{"year":2019,"finding":"Global Kcnip3 knockout in rats enhances acute and chronic inflammatory pain sensitivity, increases anxiety and depression-like behavior, and causes transcriptional changes in forebrain cortex including upregulation of dopaminergic transmission genes (Nr4a2, Ret, Cplx3, Rgs9) and downregulation of others (Col3a1, Ddc), indicating KChIP3 normally restrains pain and negative emotional processing through transcriptional control.","method":"Kcnip3 knockout rats, nociceptive behavioral assays, RNA-Seq transcriptomics, qPCR validation","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — KO rat with defined behavioral and transcriptional phenotype, transcriptomic profiling","pmids":["30740043"],"is_preprint":false},{"year":2022,"finding":"DREAM/KChIP3 transcriptionally represses A20 (TNFAIP3) in fibroblasts; DREAM-null mice have elevated A20 expression and are protected from fibrosis, while A20-haploinsufficient or fibroblast-specific A20-deleted mice develop SSc-like fibrosis. TGF-β induces A20 in DREAM-null but not wild-type fibroblasts, placing DREAM upstream of A20 in a fibrosis regulatory axis.","method":"DREAM knockout mice, fibroblast-specific A20 knockout mice, ChIP/gene expression assays, TGF-β stimulation, bleomycin fibrosis model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic models with epistasis establishing DREAM→A20 repression, replicated in mice and human SSc tissue","pmids":["36289219"],"is_preprint":false}],"current_model":"KCNIP3/KChIP3/DREAM/calsenilin is a multifunctional neuronal calcium sensor protein that in the Ca2+-free state directly binds DRE promoter elements to repress transcription (including prodynorphin, BDNF, GFAP, and A20), while in the Ca2+-bound state it associates with the N-terminal T1 domain of Kv4 α-subunits (Kv4.2/Kv4.3) to promote their tetramerization, ER export, surface trafficking, and A-type K+ channel function; it additionally interacts with TRPV1 (via its N-terminal 31–50 fragment) to reduce channel surface expression, with hexokinase I (Ca2+-dependently, via its N-terminus) to promote apoptosis, and with the TSH receptor to enhance Gαs coupling, making KChIP3 a Ca2+-regulated molecular switch that links intracellular calcium levels to membrane excitability, transcriptional programs governing pain, immunity, and development, and apoptosis."},"narrative":{"teleology":[{"year":2001,"claim":"Identifying KChIP3/DREAM as a Ca²⁺-regulated transcriptional repressor that binds DRE sites in the Ca²⁺-free state established the founding mechanism — a calcium-sensing switch controlling gene expression.","evidence":"In vitro DNA-binding assays, Ca²⁺-dependent transcriptional repression assays, EF-hand mutant analysis","pmids":["11162748"],"confidence":"High","gaps":["Full repertoire of DRE-containing target genes unknown","Structural basis of Ca²⁺-induced conformational change releasing DNA not yet resolved at atomic level","Mechanism of nuclear import/export regulation unclear"]},{"year":2001,"claim":"Demonstrating that KChIP3 associates with Kv4.3 in dopaminergic neurons and that its mRNA level linearly determines A-type current density and pacemaker frequency established KChIP3 as a direct tuner of neuronal excitability, distinct from its transcriptional role.","evidence":"Single-cell RT-PCR quantification combined with patch-clamp electrophysiology in substantia nigra dopaminergic neurons","pmids":["11598014"],"confidence":"High","gaps":["Whether KChIP3 splice variants differ in channel-modulatory capacity not resolved","Mechanism by which KChIP3 promotes channel trafficking versus gating modulation not separated"]},{"year":2001,"claim":"Showing that KChIP3 overexpression induces caspase-dependent apoptosis and that its knockdown attenuates Fas- and Ca²⁺-stress-induced cell death revealed a third functional axis — pro-apoptotic signaling.","evidence":"Antisense knockdown, overexpression, caspase activity assays, DNA laddering in cultured cells","pmids":["11259376"],"confidence":"Medium","gaps":["Direct apoptotic effector mechanism (mitochondrial versus death-receptor pathway contribution) not dissected","Physiological relevance of KChIP3-mediated apoptosis in vivo not confirmed at this stage"]},{"year":2004,"claim":"Discovering that KChIP3 promotes Kv4.2 tetramerization within the ER — rescuing assembly-deficient Zn²⁺-site mutants — separated its role as a chaperone for subunit assembly from a general trafficking factor.","evidence":"Mutagenesis of Kv4.2 Zn²⁺-coordination residues, co-expression with KChIP3, electrophysiology and surface expression assays","pmids":["15485870"],"confidence":"High","gaps":["Stoichiometry of KChIP3 in the assembled tetramer not definitively resolved","Whether KChIP3 dissociates after ER exit or remains in the surface complex unclear"]},{"year":2005,"claim":"Demonstrating that KChIP3, DPP10, and Kv4.2 form a ternary complex with distinct ISA-like kinetics showed that native A-type channels are multisubunit assemblies requiring both auxiliary proteins for physiological gating.","evidence":"Co-immunoprecipitation from rat brain and heterologous expression electrophysiology in oocytes and CHO cells","pmids":["16123112"],"confidence":"High","gaps":["Cryo-EM or crystal structure of the full ternary complex not available","Whether DPP10 and KChIP3 compete for overlapping binding sites on Kv4.2 not addressed"]},{"year":2009,"claim":"KChIP3 knockout mice showing enhanced contextual fear memory — with a shift from membrane-associated (Kv4-bound) to nuclear KChIP3 after fear conditioning — revealed that activity-dependent redistribution between channel modulation and transcriptional repression is a physiological regulatory mechanism during memory consolidation.","evidence":"KChIP3 knockout mouse fear conditioning, subcellular fractionation, co-immunoprecipitation, RT-PCR for prodynorphin","pmids":["19223600"],"confidence":"Medium","gaps":["Signaling pathway controlling KChIP3 membrane-to-nucleus translocation not identified","Contribution of prodynorphin repression versus Kv4 modulation to the memory phenotype not separated"]},{"year":2009,"claim":"Identifying DREAM/KChIP3 as a direct interactor of the TSH receptor that enhances Gαs coupling, with transgenic overexpression causing thyroid enlargement mirrored in human goiters, extended KChIP3 function to GPCR signaling outside the nervous system.","evidence":"Protein-protein interaction assay, transgenic mouse model, immunohistochemistry on human multinodular goiter tissue","pmids":["19299442"],"confidence":"Medium","gaps":["Binding interface between DREAM and TSHR not mapped","Whether KChIP3 modulates other GPCRs not tested"]},{"year":2009,"claim":"Placing KChIP3 on the GFAP promoter DRE as a mediator of PACAP–cAMP–Ca²⁺-driven astrogliogenesis, with KO mice showing altered neuron/astrocyte ratios, established a developmental role for DREAM-mediated transcriptional control.","evidence":"Reporter assays, DREAM knockout mice developmental phenotype, pharmacological cAMP/Ca²⁺ manipulation","pmids":["19238593"],"confidence":"Medium","gaps":["Whether DREAM represses or activates GFAP depending on Ca²⁺ state not fully dissected","Cell-type-specific conditional KO not performed"]},{"year":2010,"claim":"Showing that KChIP2, KChIP3, and KChIP4 are interdependently required for cortical IA currents, with compensatory upregulation upon single-gene loss, revealed functional redundancy among KChIP family members in vivo.","evidence":"Co-immunoprecipitation from mouse cortex, KChIP2/3 knockout and RNAi triple-knockdown electrophysiology","pmids":["20943905"],"confidence":"High","gaps":["Unique versus redundant contributions of each KChIP isoform to channel kinetics not fully separated","Triple KO animal not generated"]},{"year":2013,"claim":"Mapping the Ca²⁺-dependent interaction of KChIP3 with hexokinase I and showing that KChIP3 displaces hexokinase from mitochondria to promote caspase-3 activation provided a molecular mechanism for the previously observed pro-apoptotic activity.","evidence":"Co-immunoprecipitation, deletion/Ca²⁺-binding mutants, caspase-3 activity assays, mitochondrial fractionation","pmids":["23524266"],"confidence":"Medium","gaps":["In vivo validation of hexokinase displacement during physiological apoptosis not performed","Whether other KChIP family members share this pro-apoptotic mechanism unknown"]},{"year":2014,"claim":"Biophysical characterization of KChIP3–Kv4.3 binding as Ca²⁺-dependent and identification of Tyr-174/Phe-218 as critical residues for drug-enhanced interaction provided the first quantitative binding model for the KChIP3–Kv4 interface.","evidence":"Fluorescence spectroscopy, isothermal calorimetry, docking simulations, site-directed mutagenesis","pmids":["25228688"],"confidence":"High","gaps":["High-resolution co-crystal structure of KChIP3–Kv4.3 complex not obtained","Role of these residues in native neuronal channels not tested"]},{"year":2018,"claim":"Demonstrating that the KChIP3 N-terminal fragment (aa 31–50) binds TRPV1 intracellular domains to reduce channel surface expression and that a cell-permeable version of this peptide alleviates inflammatory hyperalgesia in vivo established KChIP3 as an endogenous negative regulator of pain-channel trafficking.","evidence":"Co-immunoprecipitation, peptide competition, Ca²⁺ imaging, Kcnip3 KO rat model, CFA inflammatory pain model with TAT-peptide rescue","pmids":["29335353"],"confidence":"High","gaps":["Structural basis of the 31–50 peptide–TRPV1 interaction not resolved","Whether KChIP3 regulates TRPV1 gating in addition to trafficking not determined"]},{"year":2019,"claim":"Global Kcnip3 KO rats exhibiting enhanced pain sensitivity, anxiety, and depression alongside cortical transcriptomic changes in dopaminergic genes confirmed KChIP3 as a broad restraint on nociception and negative affect, acting through transcriptional regulation.","evidence":"Kcnip3 KO rats, nociceptive/affective behavioral assays, RNA-Seq and qPCR","pmids":["30740043"],"confidence":"Medium","gaps":["Relative contribution of Kv4 channel modulation versus transcriptional repression to the pain/affect phenotype not dissected","Circuit-level mechanisms linking cortical transcriptomic changes to behavior not identified"]},{"year":2022,"claim":"Establishing that DREAM transcriptionally represses A20/TNFAIP3 and that DREAM-null mice are protected from fibrosis while A20-deficient fibroblasts develop SSc-like fibrosis defined a DREAM→A20 axis controlling extracellular matrix homeostasis, extending KChIP3 function to fibrotic disease.","evidence":"DREAM KO and fibroblast-specific A20 KO mice, ChIP, gene expression, TGF-β stimulation, bleomycin fibrosis model, human SSc tissue","pmids":["36289219"],"confidence":"High","gaps":["Whether the DREAM–A20 axis operates in other fibrotic organs beyond skin not tested","Direct DRE site in the A20 promoter not mapped at nucleotide resolution"]},{"year":null,"claim":"A unified structural and signaling model explaining how Ca²⁺ binding simultaneously controls KChIP3's partitioning among DNA, Kv4 channels, TRPV1, hexokinase I, and TSHR — and whether these interactions are mutually exclusive or context-dependent — remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of full-length KChIP3 in complex with any partner","Quantitative model of Ca²⁺-dependent partitioning among multiple interaction partners absent","Cell-type-specific conditional knockouts needed to separate transcriptional from channel-modulatory functions in vivo"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,6,8,10,16]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,6,8,10,15,16]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,4,5,9,12,13]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[0,12]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,6,8,10,16]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[5]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,4,6,9,13]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,4,5,6,9,13,15]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,8,10,16]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,8]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,11]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,16]}],"complexes":["Kv4.2/KChIP3 channel complex","Kv4.2/KChIP3/DPP10 ternary complex","Kv4.3/KChIP3 channel complex"],"partners":["KCND2","KCND3","DPP10","TRPV1","HK1","TSHR","KCNIP2","KCNIP4"],"other_free_text":[]},"mechanistic_narrative":"KCNIP3 (also known as DREAM/calsenilin/KChIP3) is a multifunctional neuronal calcium sensor that acts as a Ca²⁺-regulated molecular switch coupling intracellular calcium levels to transcriptional repression, ion channel assembly, pain processing, and apoptosis. In the Ca²⁺-free state, KChIP3 binds directly to downstream regulatory element (DRE) sites in gene promoters to repress transcription of targets including prodynorphin, GFAP, A20/TNFAIP3, and immunoglobulin-related genes, while Ca²⁺ binding releases it from DNA and promotes its association with Kv4 α-subunits (Kv4.2/Kv4.3), facilitating subunit tetramerization in the ER, surface trafficking, and generation of A-type potassium currents that regulate neuronal excitability and pacemaker frequency [PMID:11162748, PMID:15485870, PMID:11598014, PMID:16123112]. KChIP3 additionally interacts with TRPV1 via its N-terminal residues 31–50 to reduce channel surface expression and Ca²⁺ influx, and Kcnip3 knockout in rats enhances inflammatory pain sensitivity and anxiety-like behavior, establishing KChIP3 as an endogenous restraint on nociception and negative affect [PMID:29335353, PMID:30740043]. Through Ca²⁺-dependent interaction with hexokinase I, KChIP3 displaces hexokinase from mitochondria and promotes caspase-dependent apoptosis, and its transcriptional repression of A20 positions it as a pro-fibrotic factor whose loss protects against systemic sclerosis-like fibrosis [PMID:23524266, PMID:36289219]."},"prefetch_data":{"uniprot":{"accession":"Q9Y2W7","full_name":"Calsenilin","aliases":["A-type potassium channel modulatory protein 3","DRE-antagonist modulator","DREAM","Kv channel-interacting protein 3","KChIP3"],"length_aa":256,"mass_kda":29.2,"function":"Calcium-dependent transcriptional repressor that binds to the DRE element of genes including PDYN and FOS. Affinity for DNA is reduced upon binding to calcium and enhanced by binding to magnesium. Seems to be involved in nociception (By similarity) Regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels, such as KCND2/Kv4.2 and KCND3/Kv4.3. Modulates channel expression at the cell membrane, gating characteristics, inactivation kinetics and rate of recovery from inactivation in a calcium-dependent and isoform-specific manner May play a role in the regulation of PSEN2 proteolytic processing and apoptosis. Together with PSEN2 involved in modulation of amyloid-beta formation","subcellular_location":"Cytoplasm; Cell membrane; Endoplasmic reticulum; Golgi apparatus; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9Y2W7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNIP3","classification":"Not Classified","n_dependent_lines":34,"n_total_lines":1208,"dependency_fraction":0.028145695364238412},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNIP3","total_profiled":1310},"omim":[{"mim_id":"608182","title":"POTASSIUM CHANNEL-INTERACTING PROTEIN 4","url":"https://www.omim.org/entry/608182"},{"mim_id":"607042","title":"CLN3 LYSOSOMAL/ENDOSOMAL TRANSMEMBRANE PROTEIN, BATTENIN; CLN3","url":"https://www.omim.org/entry/607042"},{"mim_id":"604662","title":"POTASSIUM CHANNEL-INTERACTING PROTEIN 3; KCNIP3","url":"https://www.omim.org/entry/604662"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":30.4},{"tissue":"lymphoid tissue","ntpm":22.9},{"tissue":"parathyroid gland","ntpm":25.1}],"url":"https://www.proteinatlas.org/search/KCNIP3"},"hgnc":{"alias_symbol":["DREAM","KCHIP3"],"prev_symbol":["CSEN"]},"alphafold":{"accession":"Q9Y2W7","domains":[{"cath_id":"1.10.238.10","chopping":"89-253","consensus_level":"medium","plddt":81.9925,"start":89,"end":253}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2W7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2W7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2W7-F1-predicted_aligned_error_v6.png","plddt_mean":69.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNIP3","jax_strain_url":"https://www.jax.org/strain/search?query=KCNIP3"},"sequence":{"accession":"Q9Y2W7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y2W7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y2W7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2W7"}},"corpus_meta":[{"pmid":"29125603","id":"PMC_29125603","title":"Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/29125603","citation_count":520,"is_preprint":false},{"pmid":"26384566","id":"PMC_26384566","title":"The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26384566","citation_count":278,"is_preprint":false},{"pmid":"11598014","id":"PMC_11598014","title":"Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11598014","citation_count":245,"is_preprint":false},{"pmid":"17925349","id":"PMC_17925349","title":"Dialogue on reverse-engineering assessment and methods: the DREAM of high-throughput pathway inference.","date":"2007","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17925349","citation_count":223,"is_preprint":false},{"pmid":"32730587","id":"PMC_32730587","title":"Dream: powerful differential expression analysis for repeated measures designs.","date":"2021","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32730587","citation_count":219,"is_preprint":false},{"pmid":"28799433","id":"PMC_28799433","title":"Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.","date":"2017","source":"Critical reviews in biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28799433","citation_count":197,"is_preprint":false},{"pmid":"28073865","id":"PMC_28073865","title":"Angiogenic gene therapy in cardiovascular diseases: dream or vision?","date":"2017","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/28073865","citation_count":141,"is_preprint":false},{"pmid":"27992798","id":"PMC_27992798","title":"Peroxygenases en route to becoming dream catalysts. What are the opportunities and challenges?","date":"2016","source":"Current opinion in chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/27992798","citation_count":132,"is_preprint":false},{"pmid":"25336116","id":"PMC_25336116","title":"Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?","date":"2014","source":"Annals of oncology : official journal of the European Society for Medical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25336116","citation_count":120,"is_preprint":false},{"pmid":"16123112","id":"PMC_16123112","title":"Multiprotein assembly of Kv4.2, KChIP3 and DPP10 produces ternary channel complexes with ISA-like properties.","date":"2005","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16123112","citation_count":115,"is_preprint":false},{"pmid":"33488631","id":"PMC_33488631","title":"Allogeneic CAR Cell Therapy-More Than a Pipe Dream.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33488631","citation_count":104,"is_preprint":false},{"pmid":"25917549","id":"PMC_25917549","title":"Structural mechanisms of DREAM complex assembly and regulation.","date":"2015","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/25917549","citation_count":96,"is_preprint":false},{"pmid":"27919908","id":"PMC_27919908","title":"Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/27919908","citation_count":90,"is_preprint":false},{"pmid":"38701786","id":"PMC_38701786","title":"Molecular glues for protein-protein interactions: Progressing toward a new dream.","date":"2024","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/38701786","citation_count":87,"is_preprint":false},{"pmid":"28572607","id":"PMC_28572607","title":"Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28572607","citation_count":86,"is_preprint":false},{"pmid":"24120737","id":"PMC_24120737","title":"Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?","date":"2013","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/24120737","citation_count":77,"is_preprint":false},{"pmid":"21900204","id":"PMC_21900204","title":"Crowdsourcing network inference: the DREAM predictive signaling network challenge.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900204","citation_count":76,"is_preprint":false},{"pmid":"12553744","id":"PMC_12553744","title":"L-arginine in cardiovascular disease: dream or reality?","date":"2002","source":"Vascular medicine (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12553744","citation_count":69,"is_preprint":false},{"pmid":"11259376","id":"PMC_11259376","title":"Pro-apoptotic function of calsenilin/DREAM/KChIP3.","date":"2001","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11259376","citation_count":65,"is_preprint":false},{"pmid":"35266971","id":"PMC_35266971","title":"Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study.","date":"2022","source":"JAMA ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/35266971","citation_count":61,"is_preprint":false},{"pmid":"18682690","id":"PMC_18682690","title":"Vaccine adjuvants: the dream becomes real.","date":"2008","source":"Human vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/18682690","citation_count":55,"is_preprint":false},{"pmid":"14720210","id":"PMC_14720210","title":"Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-beta exposure.","date":"2004","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14720210","citation_count":54,"is_preprint":false},{"pmid":"30206359","id":"PMC_30206359","title":"The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30206359","citation_count":54,"is_preprint":false},{"pmid":"25620966","id":"PMC_25620966","title":"Reconstructing each cell's genome within complex microbial communities-dream or reality?","date":"2015","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/25620966","citation_count":53,"is_preprint":false},{"pmid":"10942044","id":"PMC_10942044","title":"Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?","date":"2000","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10942044","citation_count":52,"is_preprint":false},{"pmid":"25737279","id":"PMC_25737279","title":"The DREAM complex promotes gene body H2A.Z for target repression.","date":"2015","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/25737279","citation_count":52,"is_preprint":false},{"pmid":"33626321","id":"PMC_33626321","title":"PAF remodels the DREAM complex to bypass cell quiescence and promote lung tumorigenesis.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33626321","citation_count":50,"is_preprint":false},{"pmid":"24784572","id":"PMC_24784572","title":"Universal influenza vaccines, a dream to be realized soon.","date":"2014","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/24784572","citation_count":49,"is_preprint":false},{"pmid":"19223600","id":"PMC_19223600","title":"The role of calsenilin/DREAM/KChIP3 in contextual fear conditioning.","date":"2009","source":"Learning & memory (Cold Spring Harbor, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/19223600","citation_count":49,"is_preprint":false},{"pmid":"31940974","id":"PMC_31940974","title":"Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?","date":"2020","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/31940974","citation_count":48,"is_preprint":false},{"pmid":"20943905","id":"PMC_20943905","title":"Interdependent roles for accessory KChIP2, KChIP3, and KChIP4 subunits in the generation of Kv4-encoded IA channels in cortical pyramidal neurons.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20943905","citation_count":48,"is_preprint":false},{"pmid":"27867014","id":"PMC_27867014","title":"The cave microbiome as a source for drug discovery: Reality or pipe dream?","date":"2016","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27867014","citation_count":47,"is_preprint":false},{"pmid":"36959262","id":"PMC_36959262","title":"The DREAM complex functions as conserved master regulator of somatic DNA-repair capacities.","date":"2023","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36959262","citation_count":46,"is_preprint":false},{"pmid":"34207126","id":"PMC_34207126","title":"TMB in NSCLC: A Broken Dream?","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34207126","citation_count":46,"is_preprint":false},{"pmid":"11162748","id":"PMC_11162748","title":"Ca2+-dependent transcriptional repression and derepression: DREAM, a direct effector.","date":"2001","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11162748","citation_count":44,"is_preprint":false},{"pmid":"34207062","id":"PMC_34207062","title":"Cancer Vaccines: Promising Therapeutics or an Unattainable Dream.","date":"2021","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/34207062","citation_count":42,"is_preprint":false},{"pmid":"17763371","id":"PMC_17763371","title":"Breast cancer vaccines: promise for the future or pipe dream?","date":"2007","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17763371","citation_count":42,"is_preprint":false},{"pmid":"32060406","id":"PMC_32060406","title":"Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease.","date":"2020","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/32060406","citation_count":41,"is_preprint":false},{"pmid":"34139170","id":"PMC_34139170","title":"Advances in systems biology modeling: 10 years of crowdsourcing DREAM challenges.","date":"2021","source":"Cell systems","url":"https://pubmed.ncbi.nlm.nih.gov/34139170","citation_count":41,"is_preprint":false},{"pmid":"34583930","id":"PMC_34583930","title":"The DREAM complex represses growth in response to DNA damage in Arabidopsis.","date":"2021","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/34583930","citation_count":38,"is_preprint":false},{"pmid":"15485870","id":"PMC_15485870","title":"KChIP3 rescues the functional expression of Shal channel tetramerization mutants.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15485870","citation_count":37,"is_preprint":false},{"pmid":"18648845","id":"PMC_18648845","title":"Immunohistochemical assessment of protein phosphorylation state: the dream and the reality.","date":"2008","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18648845","citation_count":37,"is_preprint":false},{"pmid":"37219418","id":"PMC_37219418","title":"Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37219418","citation_count":35,"is_preprint":false},{"pmid":"28364229","id":"PMC_28364229","title":"Invention and Early History of Morpholinos: From Pipe Dream to Practical Products.","date":"2017","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/28364229","citation_count":35,"is_preprint":false},{"pmid":"17157222","id":"PMC_17157222","title":"Adult stem cell therapy: dream or reality?","date":"2006","source":"Transplant immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17157222","citation_count":34,"is_preprint":false},{"pmid":"34496610","id":"PMC_34496610","title":"DREAM On: Cell Cycle Control in Development and Disease.","date":"2021","source":"Annual review of genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34496610","citation_count":34,"is_preprint":false},{"pmid":"24445638","id":"PMC_24445638","title":"DNA testing for malignant hyperthermia: the reality and the dream.","date":"2014","source":"Anesthesia and analgesia","url":"https://pubmed.ncbi.nlm.nih.gov/24445638","citation_count":34,"is_preprint":false},{"pmid":"37488850","id":"PMC_37488850","title":"The concept of gene therapy for glaucoma: the dream that has not come true yet.","date":"2024","source":"Neural regeneration research","url":"https://pubmed.ncbi.nlm.nih.gov/37488850","citation_count":33,"is_preprint":false},{"pmid":"30207101","id":"PMC_30207101","title":"Checkpoint-inhibition in ovarian cancer: rising star or just a dream?","date":"2018","source":"Journal of gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30207101","citation_count":31,"is_preprint":false},{"pmid":"22564294","id":"PMC_22564294","title":"Pharma-metabolomics in neonatology: is it a dream or a fact?","date":"2012","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/22564294","citation_count":31,"is_preprint":false},{"pmid":"30517867","id":"PMC_30517867","title":"The HDAC-Associated Sin3B Protein Represses DREAM Complex Targets and Cooperates with APC/C to Promote Quiescence.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30517867","citation_count":30,"is_preprint":false},{"pmid":"28987629","id":"PMC_28987629","title":"Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?","date":"2017","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/28987629","citation_count":29,"is_preprint":false},{"pmid":"33064963","id":"PMC_33064963","title":"Cardiac Regeneration: New Hope for an Old Dream.","date":"2020","source":"Annual review of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33064963","citation_count":29,"is_preprint":false},{"pmid":"31025625","id":"PMC_31025625","title":"The Dream of a Mycobacterium.","date":"2019","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/31025625","citation_count":29,"is_preprint":false},{"pmid":"32872424","id":"PMC_32872424","title":"Measuring Extracellular Vesicles by Conventional Flow Cytometry: Dream or Reality?","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32872424","citation_count":28,"is_preprint":false},{"pmid":"25228688","id":"PMC_25228688","title":"Modulation of the voltage-gated potassium channel (Kv4.3) and the auxiliary protein (KChIP3) interactions by the current activator NS5806.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25228688","citation_count":28,"is_preprint":false},{"pmid":"32741893","id":"PMC_32741893","title":"Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort.","date":"2020","source":"Journal of atherosclerosis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/32741893","citation_count":28,"is_preprint":false},{"pmid":"35700053","id":"PMC_35700053","title":"Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35700053","citation_count":28,"is_preprint":false},{"pmid":"24710275","id":"PMC_24710275","title":"Loss of the mammalian DREAM complex deregulates chondrocyte proliferation.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24710275","citation_count":27,"is_preprint":false},{"pmid":"35988852","id":"PMC_35988852","title":"Shorter antibiotic courses in the immunocompromised: the impossible dream?","date":"2022","source":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35988852","citation_count":26,"is_preprint":false},{"pmid":"24780735","id":"PMC_24780735","title":"Do endothelial cells dream of eclectic shape?","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24780735","citation_count":24,"is_preprint":false},{"pmid":"34190579","id":"PMC_34190579","title":"PD-L1 expression as a predictive biomarker for immune checkpoint inhibitors: between a dream and a nightmare.","date":"2021","source":"Immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/34190579","citation_count":24,"is_preprint":false},{"pmid":"25053843","id":"PMC_25053843","title":"dREAM co-operates with insulator-binding proteins and regulates expression at divergently paired genes.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25053843","citation_count":23,"is_preprint":false},{"pmid":"28240187","id":"PMC_28240187","title":"The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.","date":"2017","source":"CNS & neurological disorders drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/28240187","citation_count":23,"is_preprint":false},{"pmid":"19238593","id":"PMC_19238593","title":"PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis.","date":"2009","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/19238593","citation_count":22,"is_preprint":false},{"pmid":"19299442","id":"PMC_19299442","title":"The DREAM protein is associated with thyroid enlargement and nodular development.","date":"2009","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19299442","citation_count":22,"is_preprint":false},{"pmid":"23738299","id":"PMC_23738299","title":"The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair?","date":"2012","source":"Muscles, ligaments and tendons journal","url":"https://pubmed.ncbi.nlm.nih.gov/23738299","citation_count":21,"is_preprint":false},{"pmid":"21059893","id":"PMC_21059893","title":"Increased B cell proliferation and reduced Ig production in DREAM transgenic mice.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21059893","citation_count":20,"is_preprint":false},{"pmid":"37406784","id":"PMC_37406784","title":"Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/37406784","citation_count":19,"is_preprint":false},{"pmid":"29335353","id":"PMC_29335353","title":"KChIP3 N-Terminal 31-50 Fragment Mediates Its Association with TRPV1 and Alleviates Inflammatory Hyperalgesia in Rats.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29335353","citation_count":19,"is_preprint":false},{"pmid":"29408367","id":"PMC_29408367","title":"Review: Limb regeneration in humans: Dream or reality?","date":"2018","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/29408367","citation_count":19,"is_preprint":false},{"pmid":"33755733","id":"PMC_33755733","title":"Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models.","date":"2021","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33755733","citation_count":19,"is_preprint":false},{"pmid":"38783095","id":"PMC_38783095","title":"The p21CIP1-CDK4-DREAM axis is a master regulator of genotoxic stress-induced cellular senescence.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/38783095","citation_count":18,"is_preprint":false},{"pmid":"28372287","id":"PMC_28372287","title":"Organ reconstruction: Dream or reality for the future.","date":"2017","source":"Bio-medical materials and engineering","url":"https://pubmed.ncbi.nlm.nih.gov/28372287","citation_count":18,"is_preprint":false},{"pmid":"27454358","id":"PMC_27454358","title":"Capturing Darwin's dream.","date":"2016","source":"Molecular ecology resources","url":"https://pubmed.ncbi.nlm.nih.gov/27454358","citation_count":18,"is_preprint":false},{"pmid":"36289219","id":"PMC_36289219","title":"Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36289219","citation_count":18,"is_preprint":false},{"pmid":"37798168","id":"PMC_37798168","title":"Novel technologies are turning a dream into reality: conditionally replicating viruses as vaccines.","date":"2023","source":"Trends in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/37798168","citation_count":18,"is_preprint":false},{"pmid":"33139668","id":"PMC_33139668","title":"Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33139668","citation_count":17,"is_preprint":false},{"pmid":"27147118","id":"PMC_27147118","title":"FMRP Mediates Chronic Ethanol-Induced Changes in NMDA, Kv4.2, and KChIP3 Expression in the Hippocampus.","date":"2016","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/27147118","citation_count":17,"is_preprint":false},{"pmid":"31192694","id":"PMC_31192694","title":"Electroacupuncture regulates the DREAM/NF-κB signalling pathway and ameliorates cyclophosphamide-induced immunosuppression in mice.","date":"2019","source":"Acupuncture in medicine : journal of the British Medical Acupuncture Society","url":"https://pubmed.ncbi.nlm.nih.gov/31192694","citation_count":17,"is_preprint":false},{"pmid":"36552897","id":"PMC_36552897","title":"Therapeutic Potential of VEGF-B in Coronary Heart Disease and Heart Failure: Dream or Vision?","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36552897","citation_count":16,"is_preprint":false},{"pmid":"34638334","id":"PMC_34638334","title":"p53-Dependent Repression: DREAM or Reality?","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34638334","citation_count":16,"is_preprint":false},{"pmid":"18363511","id":"PMC_18363511","title":"Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?","date":"2008","source":"Expert opinion on investigational drugs","url":"https://pubmed.ncbi.nlm.nih.gov/18363511","citation_count":16,"is_preprint":false},{"pmid":"21786202","id":"PMC_21786202","title":"Building the DREAM interactome.","date":"2011","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21786202","citation_count":16,"is_preprint":false},{"pmid":"34774049","id":"PMC_34774049","title":"DREAM: a database of experimentally supported protein-coding RNAs and drug associations in human cancer.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34774049","citation_count":16,"is_preprint":false},{"pmid":"35909975","id":"PMC_35909975","title":"Plasmodium vivax Duffy Binding Protein-Based Vaccine: a Distant Dream.","date":"2022","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/35909975","citation_count":16,"is_preprint":false},{"pmid":"26885443","id":"PMC_26885443","title":"The association of mammalian DREAM complex and HPV16 E7 proteins.","date":"2015","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26885443","citation_count":16,"is_preprint":false},{"pmid":"19779746","id":"PMC_19779746","title":"Universal species concept: pipe dream or a step toward unifying biology?","date":"2009","source":"Journal of industrial microbiology & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/19779746","citation_count":15,"is_preprint":false},{"pmid":"30510457","id":"PMC_30510457","title":"Molecular characterization and biomarker identification in colorectal cancer: Toward realization of the precision medicine dream.","date":"2018","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/30510457","citation_count":15,"is_preprint":false},{"pmid":"37644845","id":"PMC_37644845","title":"Would doctors dream of electric blood bankers? Large language model-based artificial intelligence performs well in many aspects of transfusion medicine.","date":"2023","source":"Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/37644845","citation_count":15,"is_preprint":false},{"pmid":"30740043","id":"PMC_30740043","title":"Global Gene Knockout of Kcnip3 Enhances Pain Sensitivity and Exacerbates Negative Emotions in Rats.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30740043","citation_count":15,"is_preprint":false},{"pmid":"37144564","id":"PMC_37144564","title":"Vaccinal effect of HIV-1 antibody therapy: dream or reality?","date":"2023","source":"Current opinion in HIV and AIDS","url":"https://pubmed.ncbi.nlm.nih.gov/37144564","citation_count":15,"is_preprint":false},{"pmid":"39448571","id":"PMC_39448571","title":"PCLAF-DREAM drives alveolar cell plasticity for lung regeneration.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39448571","citation_count":14,"is_preprint":false},{"pmid":"33932409","id":"PMC_33932409","title":"Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?","date":"2021","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/33932409","citation_count":14,"is_preprint":false},{"pmid":"21867797","id":"PMC_21867797","title":"Development of neuromodulation treatments in a large animal model--do neurosurgeons dream of electric pigs?","date":"2011","source":"Progress in brain research","url":"https://pubmed.ncbi.nlm.nih.gov/21867797","citation_count":14,"is_preprint":false},{"pmid":"23560148","id":"PMC_23560148","title":"Chemoprevention of gastrointestinal cancer: the reality and the dream.","date":"2013","source":"Gut and liver","url":"https://pubmed.ncbi.nlm.nih.gov/23560148","citation_count":14,"is_preprint":false},{"pmid":"26089020","id":"PMC_26089020","title":"Does Arabidopsis thaliana DREAM of cell cycle control?","date":"2015","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/26089020","citation_count":14,"is_preprint":false},{"pmid":"17576551","id":"PMC_17576551","title":"Lipid rafts: dream or reality for cholesterol transporters?","date":"2007","source":"European biophysics journal : EBJ","url":"https://pubmed.ncbi.nlm.nih.gov/17576551","citation_count":14,"is_preprint":false},{"pmid":"24847731","id":"PMC_24847731","title":"Lab generated retina: realizing the dream.","date":"2014","source":"Visual neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24847731","citation_count":13,"is_preprint":false},{"pmid":"23524266","id":"PMC_23524266","title":"The regulation of apoptosis by the downstream regulatory element antagonist modulator/potassium channel interacting protein 3 (DREAM/KChIP3) through interactions with hexokinase I.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23524266","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":41055,"output_tokens":4347,"usd":0.094185},"stage2":{"model":"claude-opus-4-6","input_tokens":7837,"output_tokens":4148,"usd":0.214328},"total_usd":0.308513,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"KChIP3/DREAM is a Ca2+-regulated transcriptional repressor that binds directly to downstream regulatory element (DRE) sites in DNA promoters; binding and repression occur in the Ca2+-free state, and elevated Ca2+ causes derepression by releasing DREAM from DNA.\",\n      \"method\": \"In vitro DNA-binding assays, Ca2+-dependent transcriptional repression assays, EF-hand mutant analysis\",\n      \"journal\": \"Seminars in cell & developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational mechanism described with direct DNA-binding and mutagenesis, referenced as the original discovery\",\n      \"pmids\": [\"11162748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"KChIP3 (KChip3.1 long splice variant) associates with Kv4.3 α-subunits to form A-type potassium channels in dopaminergic substantia nigra neurons; the number of KChIP3 mRNA molecules in individual neurons correlates linearly with A-type channel density and pacemaker frequency, establishing transcriptional control of KChIP3 as a mechanism for tuning firing rate.\",\n      \"method\": \"Single-cell RT-PCR quantification combined with patch-clamp electrophysiology in identified dopaminergic neurons\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — quantitative single-cell mRNA-to-current correlation with functional readout, replicated across many neurons\",\n      \"pmids\": [\"11598014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Calsenilin/DREAM/KChIP3 has a pro-apoptotic function: its overexpression induces apoptosis (cell shrinkage, DNA laddering, caspase activation), and antisense-mediated knockdown attenuates apoptosis induced by Fas, Ca2+-ionophore, or thapsigargin. Apoptosis was suppressed by caspase inhibitor Z-VAD and Bcl-XL. KChIP3 expression also increased Aβ42 production in cells co-expressing APPsw and presenilin 2.\",\n      \"method\": \"Antisense oligonucleotide knockdown, overexpression, caspase activity assays, DNA laddering, morphological analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and gain-of-function with defined apoptotic phenotype, single lab\",\n      \"pmids\": [\"11259376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Induction of calsenilin/DREAM/KChIP3 is observed in Alzheimer's disease cortex and in APP transgenic mouse brain; exposure of cultured neurons to Aβ42 induces KChIP3 protein and mRNA, and blocking KChIP3 expression protects neurons from Aβ toxicity, establishing a role for KChIP3 in Aβ-driven neurodegeneration.\",\n      \"method\": \"Immunohistochemistry on AD brain tissue, cortical neuron culture with Aβ42 treatment, antisense knockdown, cell viability assays\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — loss-of-function with specific neuroprotective phenotype, moderate mechanistic follow-up\",\n      \"pmids\": [\"14720210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"KChIP3 and DPP10 associate simultaneously with Kv4.2 to form a ternary Kv4.2/KChIP3/DPP10 macromolecular complex; this ternary complex produces ISA-like currents with very rapid recovery from inactivation (~18–26 ms) distinct from binary Kv4.2+KChIP3 or Kv4.2+DPP10 channels.\",\n      \"method\": \"Co-immunoprecipitation from rat brain and Xenopus oocytes, heterologous co-expression electrophysiology in oocytes and CHO cells\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal Co-IP in native tissue plus functional reconstitution in two expression systems\",\n      \"pmids\": [\"16123112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"KChIP3 promotes Kv4.2 subunit assembly into tetramers by binding monomeric subunits within the endoplasmic reticulum; KChIP3 rescues functional channel expression of Kv4.2 tetramerization-deficient mutants (Zn2+ site mutants) that are otherwise trapped in the ER, demonstrating a direct role in subunit assembly beyond trafficking.\",\n      \"method\": \"Mutagenesis of Zn2+-coordination residues in Kv4.2, co-expression with KChIP3, electrophysiology, surface expression assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis plus functional reconstitution clearly defining ER-based assembly role\",\n      \"pmids\": [\"15485870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"KChIP3/DREAM regulates contextual fear memory consolidation: KChIP3 knockout mice show enhanced contextual fear memory. After fear conditioning, membrane association of KChIP3 and its interaction with Kv4.2 decrease, nuclear KChIP3 increases, and prodynorphin mRNA expression decreases in WT but not KO animals, indicating a shift from channel modulation to transcriptional repression.\",\n      \"method\": \"KChIP3 knockout mouse behavior (contextual fear conditioning), subcellular fractionation, co-immunoprecipitation, RT-PCR\",\n      \"journal\": \"Learning & memory\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO behavioral phenotype with mechanistic fractionation and interaction data in single lab\",\n      \"pmids\": [\"19223600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DREAM/KChIP3 modulates TSH receptor (TSHR) activity through direct protein-protein interaction that promotes coupling between TSHR and Gαs; DREAM overexpression in transgenic mice causes marked thyroid enlargement, and elevated DREAM protein is found in human multinodular goiters.\",\n      \"method\": \"Protein-protein interaction assay, transgenic mouse model with thyroid phenotype, immunohistochemistry on human goiter tissue\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — direct interaction demonstrated with in vivo validation in transgenic model, single lab\",\n      \"pmids\": [\"19299442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PACAP-cAMP signaling promotes astrogliogenesis via a pathway in which cAMP-dependent extracellular Ca2+ entry activates DREAM/KChIP3, which is bound to DRE sites in the GFAP gene promoter, stimulating GFAP expression during astrocyte differentiation. DREAM knockout in vivo alters the numbers of neurons and astrocytes generated during development.\",\n      \"method\": \"Reporter assays, DREAM knockout mice with developmental phenotype, pharmacological manipulations of cAMP and Ca2+\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined signaling cascade with in vivo KO validation, single lab\",\n      \"pmids\": [\"19238593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"KChIP3 coimmunoprecipitates with Kv4.2 in adult mouse cortex; KChIP2, KChIP3, and KChIP4 together are required interdependently for generation of IA currents in cortical pyramidal neurons — loss of KChIP3 alone reduces IA density modestly but triggers compensatory upregulation of KChIP2 and KChIP4.\",\n      \"method\": \"Co-immunoprecipitation, KChIP2/3 knockout mice electrophysiology, RNAi triple knockdown of KChIP2/3/4\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP combined with multiple genetic loss-of-function models\",\n      \"pmids\": [\"20943905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DREAM/KChIP3 acts as a transcriptional repressor controlling B cell proliferation and Ig synthesis; transgenic mice expressing dominant-active DREAM show reduced serum Ig levels due to reduced mRNA translation (linked to decreased Eif4g3) and accelerated B cell division correlated with reduced Klf9 expression.\",\n      \"method\": \"Transgenic dominant-active DREAM mice, in vitro B cell assays, transcriptomics, pulse-chase protein synthesis experiments\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic gain-of-function with transcriptomic and translation mechanistic data, single lab\",\n      \"pmids\": [\"21059893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In the presence of Ca2+, DREAM/KChIP3 interacts directly with hexokinase I; this interaction requires the N-terminal 94 amino acids of DREAM and Ca2+ binding. DREAM overexpression reduces hexokinase I localization on mitochondria and enhances cisplatin-mediated caspase-3 activity; co-expression of hexokinase I reduces DREAM-induced apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, deletion mutants, Ca2+-binding mutants, caspase-3 activity assays, mitochondrial fractionation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — direct protein interaction with domain mapping and functional validation, single lab\",\n      \"pmids\": [\"23524266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NS5806, a Kv4 current activator, binds at a hydrophobic site on the C-terminus of KChIP3 in a calcium-dependent manner (Kd ~2–5 μM calcium-bound form). KChIP3 association with the Kv4.3 N-terminus is itself calcium-dependent. NS5806 increases KChIP3–Kv4.3 affinity and decreases their dissociation rate; Tyr-174 and Phe-218 on KChIP3 are required for drug-enhanced Kv4.3 binding.\",\n      \"method\": \"Fluorescence spectroscopy, isothermal calorimetry, docking simulations, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding quantification with mutagenesis and multiple orthogonal biophysical methods\",\n      \"pmids\": [\"25228688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The N-terminal 31–50 fragment of KChIP3 binds directly to both intracellular N- and C-termini of TRPV1, reducing TRPV1 surface localization and Ca2+ influx through the channel. Intrathecal or intraplantar delivery of a TAT-31–50 transmembrane peptide reduces TRPV1-mediated Ca2+ influx in DRG neurons and alleviates inflammatory thermal hyperalgesia in rats.\",\n      \"method\": \"Co-immunoprecipitation, co-localization, peptide competition, Ca2+ imaging, kcnip3-/- rat model (KO validation), complete Freund's adjuvant inflammatory pain model\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding domain mapping, KO rat validation, and in vivo functional rescue with defined peptide\",\n      \"pmids\": [\"29335353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Chronic ethanol exposure reduces hippocampal Kv4.2 and KChIP3 protein levels while increasing FMRP phosphorylation at S499 (via S6K1), which increases FMRP translational suppression of Kv4.2 and KChIP3 mRNAs; S6K1 inhibition prevents both the increase in phospho-FMRP and the reduction of Kv4.2/KChIP3 protein.\",\n      \"method\": \"Western blotting, FMRP-mRNA pulldown from hippocampal slice cultures, pharmacological S6K1 inhibition\",\n      \"journal\": \"Alcoholism, clinical and experimental research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — FMRP-mRNA association assay with pharmacological manipulation, single lab\",\n      \"pmids\": [\"27147118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Global Kcnip3 knockout in rats enhances acute and chronic inflammatory pain sensitivity, increases anxiety and depression-like behavior, and causes transcriptional changes in forebrain cortex including upregulation of dopaminergic transmission genes (Nr4a2, Ret, Cplx3, Rgs9) and downregulation of others (Col3a1, Ddc), indicating KChIP3 normally restrains pain and negative emotional processing through transcriptional control.\",\n      \"method\": \"Kcnip3 knockout rats, nociceptive behavioral assays, RNA-Seq transcriptomics, qPCR validation\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO rat with defined behavioral and transcriptional phenotype, transcriptomic profiling\",\n      \"pmids\": [\"30740043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DREAM/KChIP3 transcriptionally represses A20 (TNFAIP3) in fibroblasts; DREAM-null mice have elevated A20 expression and are protected from fibrosis, while A20-haploinsufficient or fibroblast-specific A20-deleted mice develop SSc-like fibrosis. TGF-β induces A20 in DREAM-null but not wild-type fibroblasts, placing DREAM upstream of A20 in a fibrosis regulatory axis.\",\n      \"method\": \"DREAM knockout mice, fibroblast-specific A20 knockout mice, ChIP/gene expression assays, TGF-β stimulation, bleomycin fibrosis model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models with epistasis establishing DREAM→A20 repression, replicated in mice and human SSc tissue\",\n      \"pmids\": [\"36289219\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNIP3/KChIP3/DREAM/calsenilin is a multifunctional neuronal calcium sensor protein that in the Ca2+-free state directly binds DRE promoter elements to repress transcription (including prodynorphin, BDNF, GFAP, and A20), while in the Ca2+-bound state it associates with the N-terminal T1 domain of Kv4 α-subunits (Kv4.2/Kv4.3) to promote their tetramerization, ER export, surface trafficking, and A-type K+ channel function; it additionally interacts with TRPV1 (via its N-terminal 31–50 fragment) to reduce channel surface expression, with hexokinase I (Ca2+-dependently, via its N-terminus) to promote apoptosis, and with the TSH receptor to enhance Gαs coupling, making KChIP3 a Ca2+-regulated molecular switch that links intracellular calcium levels to membrane excitability, transcriptional programs governing pain, immunity, and development, and apoptosis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNIP3 (also known as DREAM/calsenilin/KChIP3) is a multifunctional neuronal calcium sensor that acts as a Ca²⁺-regulated molecular switch coupling intracellular calcium levels to transcriptional repression, ion channel assembly, pain processing, and apoptosis. In the Ca²⁺-free state, KChIP3 binds directly to downstream regulatory element (DRE) sites in gene promoters to repress transcription of targets including prodynorphin, GFAP, A20/TNFAIP3, and immunoglobulin-related genes, while Ca²⁺ binding releases it from DNA and promotes its association with Kv4 α-subunits (Kv4.2/Kv4.3), facilitating subunit tetramerization in the ER, surface trafficking, and generation of A-type potassium currents that regulate neuronal excitability and pacemaker frequency [PMID:11162748, PMID:15485870, PMID:11598014, PMID:16123112]. KChIP3 additionally interacts with TRPV1 via its N-terminal residues 31–50 to reduce channel surface expression and Ca²⁺ influx, and Kcnip3 knockout in rats enhances inflammatory pain sensitivity and anxiety-like behavior, establishing KChIP3 as an endogenous restraint on nociception and negative affect [PMID:29335353, PMID:30740043]. Through Ca²⁺-dependent interaction with hexokinase I, KChIP3 displaces hexokinase from mitochondria and promotes caspase-dependent apoptosis, and its transcriptional repression of A20 positions it as a pro-fibrotic factor whose loss protects against systemic sclerosis-like fibrosis [PMID:23524266, PMID:36289219].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying KChIP3/DREAM as a Ca²⁺-regulated transcriptional repressor that binds DRE sites in the Ca²⁺-free state established the founding mechanism — a calcium-sensing switch controlling gene expression.\",\n      \"evidence\": \"In vitro DNA-binding assays, Ca²⁺-dependent transcriptional repression assays, EF-hand mutant analysis\",\n      \"pmids\": [\"11162748\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Full repertoire of DRE-containing target genes unknown\",\n        \"Structural basis of Ca²⁺-induced conformational change releasing DNA not yet resolved at atomic level\",\n        \"Mechanism of nuclear import/export regulation unclear\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating that KChIP3 associates with Kv4.3 in dopaminergic neurons and that its mRNA level linearly determines A-type current density and pacemaker frequency established KChIP3 as a direct tuner of neuronal excitability, distinct from its transcriptional role.\",\n      \"evidence\": \"Single-cell RT-PCR quantification combined with patch-clamp electrophysiology in substantia nigra dopaminergic neurons\",\n      \"pmids\": [\"11598014\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether KChIP3 splice variants differ in channel-modulatory capacity not resolved\",\n        \"Mechanism by which KChIP3 promotes channel trafficking versus gating modulation not separated\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showing that KChIP3 overexpression induces caspase-dependent apoptosis and that its knockdown attenuates Fas- and Ca²⁺-stress-induced cell death revealed a third functional axis — pro-apoptotic signaling.\",\n      \"evidence\": \"Antisense knockdown, overexpression, caspase activity assays, DNA laddering in cultured cells\",\n      \"pmids\": [\"11259376\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct apoptotic effector mechanism (mitochondrial versus death-receptor pathway contribution) not dissected\",\n        \"Physiological relevance of KChIP3-mediated apoptosis in vivo not confirmed at this stage\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovering that KChIP3 promotes Kv4.2 tetramerization within the ER — rescuing assembly-deficient Zn²⁺-site mutants — separated its role as a chaperone for subunit assembly from a general trafficking factor.\",\n      \"evidence\": \"Mutagenesis of Kv4.2 Zn²⁺-coordination residues, co-expression with KChIP3, electrophysiology and surface expression assays\",\n      \"pmids\": [\"15485870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Stoichiometry of KChIP3 in the assembled tetramer not definitively resolved\",\n        \"Whether KChIP3 dissociates after ER exit or remains in the surface complex unclear\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that KChIP3, DPP10, and Kv4.2 form a ternary complex with distinct ISA-like kinetics showed that native A-type channels are multisubunit assemblies requiring both auxiliary proteins for physiological gating.\",\n      \"evidence\": \"Co-immunoprecipitation from rat brain and heterologous expression electrophysiology in oocytes and CHO cells\",\n      \"pmids\": [\"16123112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Cryo-EM or crystal structure of the full ternary complex not available\",\n        \"Whether DPP10 and KChIP3 compete for overlapping binding sites on Kv4.2 not addressed\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"KChIP3 knockout mice showing enhanced contextual fear memory — with a shift from membrane-associated (Kv4-bound) to nuclear KChIP3 after fear conditioning — revealed that activity-dependent redistribution between channel modulation and transcriptional repression is a physiological regulatory mechanism during memory consolidation.\",\n      \"evidence\": \"KChIP3 knockout mouse fear conditioning, subcellular fractionation, co-immunoprecipitation, RT-PCR for prodynorphin\",\n      \"pmids\": [\"19223600\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Signaling pathway controlling KChIP3 membrane-to-nucleus translocation not identified\",\n        \"Contribution of prodynorphin repression versus Kv4 modulation to the memory phenotype not separated\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identifying DREAM/KChIP3 as a direct interactor of the TSH receptor that enhances Gαs coupling, with transgenic overexpression causing thyroid enlargement mirrored in human goiters, extended KChIP3 function to GPCR signaling outside the nervous system.\",\n      \"evidence\": \"Protein-protein interaction assay, transgenic mouse model, immunohistochemistry on human multinodular goiter tissue\",\n      \"pmids\": [\"19299442\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Binding interface between DREAM and TSHR not mapped\",\n        \"Whether KChIP3 modulates other GPCRs not tested\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placing KChIP3 on the GFAP promoter DRE as a mediator of PACAP–cAMP–Ca²⁺-driven astrogliogenesis, with KO mice showing altered neuron/astrocyte ratios, established a developmental role for DREAM-mediated transcriptional control.\",\n      \"evidence\": \"Reporter assays, DREAM knockout mice developmental phenotype, pharmacological cAMP/Ca²⁺ manipulation\",\n      \"pmids\": [\"19238593\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether DREAM represses or activates GFAP depending on Ca²⁺ state not fully dissected\",\n        \"Cell-type-specific conditional KO not performed\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showing that KChIP2, KChIP3, and KChIP4 are interdependently required for cortical IA currents, with compensatory upregulation upon single-gene loss, revealed functional redundancy among KChIP family members in vivo.\",\n      \"evidence\": \"Co-immunoprecipitation from mouse cortex, KChIP2/3 knockout and RNAi triple-knockdown electrophysiology\",\n      \"pmids\": [\"20943905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Unique versus redundant contributions of each KChIP isoform to channel kinetics not fully separated\",\n        \"Triple KO animal not generated\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mapping the Ca²⁺-dependent interaction of KChIP3 with hexokinase I and showing that KChIP3 displaces hexokinase from mitochondria to promote caspase-3 activation provided a molecular mechanism for the previously observed pro-apoptotic activity.\",\n      \"evidence\": \"Co-immunoprecipitation, deletion/Ca²⁺-binding mutants, caspase-3 activity assays, mitochondrial fractionation\",\n      \"pmids\": [\"23524266\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"In vivo validation of hexokinase displacement during physiological apoptosis not performed\",\n        \"Whether other KChIP family members share this pro-apoptotic mechanism unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Biophysical characterization of KChIP3–Kv4.3 binding as Ca²⁺-dependent and identification of Tyr-174/Phe-218 as critical residues for drug-enhanced interaction provided the first quantitative binding model for the KChIP3–Kv4 interface.\",\n      \"evidence\": \"Fluorescence spectroscopy, isothermal calorimetry, docking simulations, site-directed mutagenesis\",\n      \"pmids\": [\"25228688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"High-resolution co-crystal structure of KChIP3–Kv4.3 complex not obtained\",\n        \"Role of these residues in native neuronal channels not tested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that the KChIP3 N-terminal fragment (aa 31–50) binds TRPV1 intracellular domains to reduce channel surface expression and that a cell-permeable version of this peptide alleviates inflammatory hyperalgesia in vivo established KChIP3 as an endogenous negative regulator of pain-channel trafficking.\",\n      \"evidence\": \"Co-immunoprecipitation, peptide competition, Ca²⁺ imaging, Kcnip3 KO rat model, CFA inflammatory pain model with TAT-peptide rescue\",\n      \"pmids\": [\"29335353\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of the 31–50 peptide–TRPV1 interaction not resolved\",\n        \"Whether KChIP3 regulates TRPV1 gating in addition to trafficking not determined\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Global Kcnip3 KO rats exhibiting enhanced pain sensitivity, anxiety, and depression alongside cortical transcriptomic changes in dopaminergic genes confirmed KChIP3 as a broad restraint on nociception and negative affect, acting through transcriptional regulation.\",\n      \"evidence\": \"Kcnip3 KO rats, nociceptive/affective behavioral assays, RNA-Seq and qPCR\",\n      \"pmids\": [\"30740043\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Relative contribution of Kv4 channel modulation versus transcriptional repression to the pain/affect phenotype not dissected\",\n        \"Circuit-level mechanisms linking cortical transcriptomic changes to behavior not identified\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Establishing that DREAM transcriptionally represses A20/TNFAIP3 and that DREAM-null mice are protected from fibrosis while A20-deficient fibroblasts develop SSc-like fibrosis defined a DREAM→A20 axis controlling extracellular matrix homeostasis, extending KChIP3 function to fibrotic disease.\",\n      \"evidence\": \"DREAM KO and fibroblast-specific A20 KO mice, ChIP, gene expression, TGF-β stimulation, bleomycin fibrosis model, human SSc tissue\",\n      \"pmids\": [\"36289219\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the DREAM–A20 axis operates in other fibrotic organs beyond skin not tested\",\n        \"Direct DRE site in the A20 promoter not mapped at nucleotide resolution\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unified structural and signaling model explaining how Ca²⁺ binding simultaneously controls KChIP3's partitioning among DNA, Kv4 channels, TRPV1, hexokinase I, and TSHR — and whether these interactions are mutually exclusive or context-dependent — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of full-length KChIP3 in complex with any partner\",\n        \"Quantitative model of Ca²⁺-dependent partitioning among multiple interaction partners absent\",\n        \"Cell-type-specific conditional knockouts needed to separate transcriptional from channel-modulatory functions in vivo\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 6, 8, 10, 16]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 6, 8, 10, 15, 16]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 4, 5, 9, 12, 13]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [0, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6, 8, 10, 16]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 4, 6, 9, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005357801\", \"supporting_discovery_ids\": [2, 11]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 4, 5, 6, 9, 13, 15]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 8, 10, 16]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 8]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 11]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 16]}\n    ],\n    \"complexes\": [\n      \"Kv4.2/KChIP3 channel complex\",\n      \"Kv4.2/KChIP3/DPP10 ternary complex\",\n      \"Kv4.3/KChIP3 channel complex\"\n    ],\n    \"partners\": [\n      \"KCND2\",\n      \"KCND3\",\n      \"DPP10\",\n      \"TRPV1\",\n      \"HK1\",\n      \"TSHR\",\n      \"KCNIP2\",\n      \"KCNIP4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}